Description: Asymchem Laboratories (Tianjin) Co., Ltd. provides contract development and manufacturing organization services in Mainland China and internationally. The company offers drug research and development, and manufacturing services for pharmaceutical and biotech companies. Its solutions range from early clinical stage to commercial stage, including research and development, and cGMP production of advanced intermediates, active pharmaceutical ingredients, and formulations, as well as clinical research services. The company also engages in the provision of pharmaceutical analysis and testing services; sale, wholesale, and retail of drugs; and pharmaceutical science and technology development activities. It has a collaboration agreement with AUM Biosciences to develop and commercialize AUM 601. The company was founded in 1999 and is headquartered in Tianjin, China. AUM Biosciences.
Home Page: www.asymchem.com.cn
No. 6 Dongting 3rd Street
Tianjin,
China
Phone:
86 22 6638 9560
Officers
| Name | Title |
|---|---|
| Dr. Hao Hong Ph.D. | Founder, Chairman & Co-CEO |
| Ms. Rui Yang | Co-CEO & Exec. Director |
| Mr. Da Zhang | CFO, Sr. VP & Exec. Director |
| Dr. James Randolph Gage Ph.D. | Chief Scientific Officer |
| Dr. Liang Hong | Exec. VP & Exec. Director |
| Mr. Chaoyong Chen | Exec. VP |
| Ms. Elut Hsu | Sr. VP of Bus. Devel. |
| Dr. Pingzhong Huang Ph.D. | Sr. VP of Process Devel. |
| Mr. Changhai Tian | Sr. VP of 5S Management |
| Ms. Xiaolian Huang | Sr. VP of Purchasing |
Exchange: SHE
Country: CN : China
Currency: Renminbi (¥)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 19.8052 |
| Price-to-Book MRQ: | 3.3181 |
| Price-to-Sales TTM: | 4.9576 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 7126 |